COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE
First Claim
Patent Images
1. An oral formulation for administering to a subject comprisinga) an imatinib compound;
- andb) an enteric matrix or enteric coating or a combination thereof;
whereby at least 80% of the imatinib compound is released in the small intestine of the subject.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention provides an oral formulation for administering to a subject comprising an imatinib compound and an enteric matrix or enteric coating or a combination thereof, whereby at least 80% of the imatinib compound is released in the small intestine of the subject. Methods of using such formulation is also provided.
101 Citations
20 Claims
-
1. An oral formulation for administering to a subject comprising
a) an imatinib compound; - and
b) an enteric matrix or enteric coating or a combination thereof; whereby at least 80% of the imatinib compound is released in the small intestine of the subject. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
- and
Specification